Press Resease

Hemostasis Products Market - Global Industry Analysis

Hemostasis Products Market by Products (Topical Hemostasis, Infusible Hemostasis, and Advanced Hemostasis) By Application (Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 26-Jul-2021 Category: Medical Device Report Format : PDF Pages: 160 Report Code: ZMR-471 Status : Published

The global Hemostasis Products market accounted for USD 6.0 Billion in 2020 and is expected to reach USD 8.5 Billion by 2028, growing at a CAGR of around 4.2% between 2021 and 2028.

Description

Market Overview                       

The global Hemostasis Products market accounted for USD 6.0 Billion in 2020 and is expected to reach USD 8.5 Billion by 2028, growing at a CAGR of around 4.2% between 2021 and 2028.           

Hemostats products are medical devices used to cease bleeding and hemorrhage caused by injuries and surgical procedures. Hemostatic comprises thrombin and collagen and they are superior to surgical hemostasis alone in controlling microvascular bleeding during cardiac surgery.  It is also reasonable to use fibrin sealants as an adjunct to surgical hemostasis to limit bleeding in cardiac and aortic surgery.

The devices are used to prevent blood loss in various conditions, especially in endoscopic procedure.

The players in the market are focusing on products launches, and mergers & acquisition in order to increase the customer base across the globe. For instance, in 2020, Ethicon, part of Johnson & Johnson launched Surgical Powder Absorbable hemostat in Australia, New Zealand, and Thailand.

COVID-19 Impact Analysis:   

Due to government-imposed lockdowns to prevent the spreading of COVID, the global Hemostasis Products industry has seen a slight decline in revenues in the short term. Because of the pandemic, the production and supply chain stopped operating around the world, potentially reducing use of the products. However, in the midst of the pandemic, there has been a surge in product demand for applications such as Surgery, Hemophilia, Myocardial Infarction, Stroke, and others. Also pharmaceutical industry which is coming under the essential services likely to boost the use of Hemostasis Products contributing to the growth of the market.  

The global markets are slowly opening to their full potential and theirs a surge in demand of the Hemostasis Products. The market would remain bullish in upcoming year. The significant decrease in the global Hemostasis Products market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Growth Factors

The hemostasis products market is likely to see noticeable development in the years to come on the back of increasing demand supported by growing surgery volumes. In addition to this, emerging market in developing nations is likely to unlock new growth opportunities for the hemostasis products market in the years to come.

Furthermore, rising prevalence of chronic conditions and rapid increment in aged population base are other factors driving the global hemostasis products market. As per the CDC statistics, over 45% of the population in the U.S suffers from minimum one chronic disease that needs important care, boosting the hemostasis products market. On the other hand, slow acceptance of enhanced hemostasis instruments in up-and-coming economies and the high price of machines might hinder the growth of the hemostasis products market in the near future.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

On the basis of Products, Hemostasis Products market has been divided as Topical Hemostasis, Infusible Hemostasis, and Advanced Hemostasis. Topical Hemostasis segment is further bi-furcated into Collagen, Oxidized Regenerated Cellulose, Gelatin, and Polysaccharide. Infusible Hemostasis segment is further bi-furcated into Platelet Concentrates from Donor Blood, FVIII Derived from Blood, Plasma, and Prothrombin Complex. The Advanced Hemostasis is further sub-segmented into Flowable, Thrombin, Fibrin, and Synthetic Sealants. Topical hemostats segment held the major share in the market. They are used with conventional treatment to provide cost-efficiency, quick and easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity. 

On the basis of Application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis Applications. Surgery dominated the Hemostasis Products industry in 2020, accounting for almost 35.5% of total Hemostasis Products sales. In the near future, the global Hemostasis Products industry is expected to be dominated by the Surgery application division

Regional Analysis Preview  

North America ruled the hemostasis products market and added up for more than 33% share in the revenues by the global hemostasis products market. The area is likely to see development in hemostasis products market at a considerable speed in the near future. The increasing numbers of complex surgeries and trauma cases, high investment is R&D, and the growth of geriatric population are also boosting the hemostasis products market in North America.

Key Market Players & Competitive Landscape

The major players operating Hemostasis Products market are Pfizer, Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Integra LifeSciences Corporation, HemCon Medical Technologies, Inc., Grifols, S.A., CSL Behring LLC, C. R. Bard, Inc. and Baxter International, Inc.

The global Hemostasis Products Market is segmented as follows:

By Products

  • Topical Hemostasis
    • Collagen
    • Oxidized Regenerated Cellulose
    • Gelatin
    • Polysaccharide
  • Infusible Hemostasis
    • Platelet Concentrates from Donor Blood
    • FVIII Derived from Blood
    • Fresh Frozen Plasma
    • Prothrombin Complex
  • Advanced Hemostasis
    • Flowable
    • Thrombin
    • Fibrin
    • Synthetic Sealants

By Application  

  • Trauma
  • Surgery
  • Hemophilia
  • Myocardial Infarction
  • Stroke
  • Thrombosis

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Products
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Hemostasis Products Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Hemostasis Products Market – Products Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Products, 2020 & 2028
    • 4.2. Topical Hemostasis
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.2.4. Cullagen
      • 4.2.5. Oxidized Regenerated Cellulose
      • 4.2.6. Gelatin
      • 4.2.7. Pulysaccharide
    • 4.3. Infusible Hemostasis
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.3.4. Platelet Concentrates from Donor Blood
      • 4.3.5. FVIII Derived from Blood
      • 4.3.6. Fresh Frozen Plasma
      • 4.3.7. Prothrombin Complex
    • 4.4. Advanced Hemostasis
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
      • 4.4.4. Flowable
      • 4.4.5. Thrombin
      • 4.4.6. Fibrin
      • 4.4.7. Synthetic Sealants
  • Chapter No. 5 Hemostasis Products Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Trauma
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Surgery
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Hemophilia
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Myocardial Infarction
      • 5.5.1. Market Size and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Stroke
      • 5.6.1. Market Size and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Thrombosis
      • 5.7.1. Market Size and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Products, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Products, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Products, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Products, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Products, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Products, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Products, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Products, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Products, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Products, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Products, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Products, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Products, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Products, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Products, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Products, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Products, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Products, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Products, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Products, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Products, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Products, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Products, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Products, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Products, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Products, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7: Hemostasis Products Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Products Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Hemostasis Products Market: Company Market Share, 2019
      • 8.1.2. Global Hemostasis Products Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Hemostasis Products Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Hemostasis Products Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Pfizer, Inc
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Medtronic plc
    • 9.3. Abbott Laboratories
    • 9.4. Johnson & Johnson
    • 9.5. Integra LifeSciences Corporation
    • 9.6. HemCon Medical Technulogies
    • 9.7. Grifuls, S.A
    • 9.8. CSL Behring LLC
    • 9.9. C. R. Bard, Inc
    • 9.10. Baxter International, Inc
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Products
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Hemostasis Products Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Products, 2020 & 2028 
FIG NO. 7. Global Hemostasis Products Market for Topical Hemostasis, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Hemostasis Products Market for Topical Hemostasis, By Country, 2020 & 2028
FIG NO. 9. Global Hemostasis Products Market for Infusible Hemostasis, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Hemostasis Products Market for Infusible Hemostasis, By Country, 2020 & 2028
FIG NO. 11. Global Hemostasis Products Market for Advanced Hemostasis, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Hemostasis Products Market for Advanced Hemostasis, By Country, 2020 & 2028
FIG NO. 13. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 14. Global Hemostasis Products Market for Trauma, Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Hemostasis Products Market for Trauma, By Country, 2020 & 2028 
FIG NO. 16. Global Hemostasis Products Market for Surgery, Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Hemostasis Products Market for Surgery, By Country, 2020 & 2028
FIG NO. 18. Global Hemostasis Products Market for Hemophilia, Revenue (USD Billion) 2016 – 2028 
FIG NO. 19. Comparative Revenue Analysis of Hemostasis Products Market for Hemophilia, By Country, 2020 & 2028
FIG NO. 20. Global Hemostasis Products Market for Myocardial Infarction, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Hemostasis Products Market for Myocardial Infarction, By Country, 2020 & 2028
FIG NO. 22. Global Hemostasis Products Market for Stroke, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Hemostasis Products Market for Stroke, By Country, 2020 & 2028
FIG NO. 24. Global Hemostasis Products Market for Thrombosis, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Hemostasis Products Market for Thrombosis, By Country, 2020 & 2028
FIG NO. 26. Global Hemostasis Products Market Revenue Share, By Region, 2020 & 2028
FIG NO. 27. North America Hemostasis Products Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 28. Porter’s Five Forces Analysis for Global Hemostasis Products Market
FIG NO. 29. PEST Analysis for Global Hemostasis Products Market
FIG NO. 30. Pricing Analysis for Global Hemostasis Products Market
FIG NO. 31. Value Chain Analysis for Global Hemostasis Products Market
FIG NO. 32. Company Share Analysis, 2019
FIG NO. 33. Radar Determinant Chart, 2019
FIG NO. 34. Company Strategic Developments – Heat Map Analysis
FIG NO. 35. Pfizer, Inc Business Segment Revenue Share, 2020 (%)
FIG NO. 36. Pfizer, Inc Geographical Segment Revenue Share, 2020 (%)
FIG NO. 37. Market Channels 
FIG NO. 38. Marketing Channel Development Trend
FIG NO. 39. Growth in World Gross Product, 2008-2018
FIG NO. 40. Research Methodology – Detailed View
FIG NO. 41. Research Methodology
 


List of Tables 

TABLE NO. 1. Global Hemostasis Products Market: Snapshot
TABLE NO. 2. Quarterly Hemostasis Products Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Hemostasis Products Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Hemostasis Products Market for Topical Hemostasis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Hemostasis Products Market for Infusible Hemostasis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Hemostasis Products Market for Advanced Hemostasis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9: Global Hemostasis Products Market for Trauma, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10: Global Hemostasis Products Market for Surgery, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Hemostasis Products Market for Hemophilia, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Hemostasis Products Market for Myocardial Infarction, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Hemostasis Products Market for Stroke, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Hemostasis Products Market for Thrombosis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Hemostasis Products Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 16: North America Hemostasis Products Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 17. North America Hemostasis Products Market Revenue, By Products, 2016 – 2028 (USD Billion)
TABLE NO. 18: North America Hemostasis Products Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 19. U.S. Hemostasis Products Market Revenue, By Products, 2016 – 2028 (USD Billion)
TABLE NO. 20. U.S. Hemostasis Products Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 21. Canada Hemostasis Products Market Revenue, By Products, 2016 – 2028 (USD Billion)
TABLE NO. 22. Canada Hemostasis Products Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 23. Mexico Hemostasis Products Market Revenue, By Products, 2016 – 2028 (USD Billion)
TABLE NO. 24. Mexico Hemostasis Products Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 25. Drivers for the Hemostasis Products Market: Impact Analysis
TABLE NO. 26. Restraints for the Hemostasis Products Market: Impact Analysis
TABLE NO. 27. Major Buyers of Hemostasis Products   
TABLE NO. 28. Distributors/Traders List of Hemostasis Products 
TABLE NO. 29. Global Hemostasis Products Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 30: Global Hemostasis Products Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   
 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Hemostasis Products market. Zion Research has collected and analyzed key data belong to the global Hemostasis Products market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Hemostasis Products across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Hemostasis Products industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Hemostasis Products market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Hemostasis is the process which helps to stop the bleeding from a cut or injury. Hemostasis products are designed to cease bleeding and hemorrhage caused by injuries and surgical procedures. Hemostasis involves forming a clot at the site of the damaged blood vessel and repairing the blood vessel. These products vary based on their ease of application, mechanism of action, adherence to tissue, composition, immunogenicity and cost.

The hemostasis product market is mainly driven by increasing demand supported by the rise in a number of surgery volumes. Furthermore, increasing geriatric population base coupled with rising incidences of chronic conditions are other impact hemostasis product market. According to the CDC statistics, more than 45% of the American population suffers from at least one chronic condition requiring important care. On the other hand, slow adoption of advanced hemostasis devices in emerging economies and the high cost of devices are expected to curb the market growth within the forecast period. Nevertheless, emerging market in developing countries is expected to open up new growth opportunities over the next few years.

Global Hemostasis Products Market

Based on products, the hemostasis product market can be segmented into topical hemostasis, infusible hemostasis, and advanced hemostasis. The topical hemostasis are further classified into collagen, oxidized regenerated cellulose, gelatin, and polysaccharide. Infusible hemostasis includes platelet concentrates from donor blood, FVIII derived from blood, fresh frozen plasma, and prothrombin complex. In 2015, hemostasis product market dominated by topical hemostats segment. Topical hemostatis are generally used in adjunction with conventional treatment to provide minimal tissue reactivity, quick and easy absorbability of the hemostatic agent, and cost-efficiency. Moreover, infusible hemostasis and advanced hemostasis segments are anticipated to exhibit significant growth in the coming years.

The hemostasis product market can be segmented on the basis of applications such as trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. Surgery segment was the largest segment in 2015. Bleeding control is an important aim in surgery. Thus, this segment is expected to witness substantial growth during the forecast period.  Trauma was another key outlet of this market and is anticipated to show strong growth in the years to come. More than 80% of trauma deaths that occur in the operating room do so as a result of hemorrhage. Traumatic injury is a major global health problem, accounting for approximately 1 in 10 deaths worldwide.

North America held the largest market share for hemostasis products in 2015. The dominance of the region was primarily due to increase health expenditure and technological advancement to provide innovative products. The increase in numbers of trauma cases and complex surgeries, growth geriatric population and high investment is research and development is also driving the hemostasis products market in North America. North America was followed by Asia Pacific which was another leading regional market in 2015. This growth is mainly due to increase aging population and advanced healthcare facilities. Latin America is also projected to expand at a noticeable growth rate during the forecast period.

Some of the key players operating in this market such as Pfizer, Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Integra LifeSciences Corporation, HemCon Medical Technologies, Inc., Grifols, S.A.,  CSL Behring LLC, C. R. Bard, Inc. and Baxter International, Inc.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Hemostasis Products Market was valued at USD 6.1 Billion in 2020.

The global Hemostasis Products Market is expected to reach USD 8.6 Billion by 2028, growing at a CAGR of 4.2% between 2021 to 2028.  

Some of the key factors driving the global Hemostasis Products Market growth are rising prevalence of chronic conditions and rapid increment in aged population base.

North America ruled the hemostasis products market and added up for more than 35% share in the revenues by the global hemostasis products market. The area is likely to see development in hemostasis products market at a considerable speed in the near future.

Some of the major players of global Hemostasis Products market includes Pfizer, Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Integra LifeSciences Corporation, HemCon Medical Technologies, Inc., Grifols, S.A., CSL Behring LLC, C. R. Bard, Inc. and Baxter International, Inc.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed